InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
1
T+90 hit rate
100%
T+90 mean return
+92.0%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Kreher Nerissa, Directrice Médicale. Director active across 2 companies, notably Entrada Therapeutics, Inc.. Cumulatively, 17 disclosures have been recorded. Split: 1 buy · 1 sell. Total volume traded: €74k. History available since 29 December 2021. The latest transaction was filed on 19 November 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Kreher Nerissa
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
21,000 shares0Common SharesSEC:0000912282-25-001290:0
3,076 shares@ US$3.25100.0% of flowCommon SharesSEC:0000912282-25-000699:0
Canonical exit: 11 Sept 2025 (T+90)
9,000 shares0Common SharesSEC:0000912282-25-000668:0
25,500 shares0Common SharesSEC:0000912282-25-000178:0
14,200 shares0Common StockSEC:0001689375-23-000062:0
10,348 shares@ US$2.1014.4% of flowCommon StockSEC:0001689375-23-000050:0
14,200 shares0Common StockSEC:0001689375-23-000027:0
28,400 shares0Common StockSEC:0001689375-23-000011:0
5,200 shares@ US$13.448447.4% of flowCommon StockSEC:0001689375-23-000001:0
8,040 shares@ US$2.1012.3% of flowCommon StockSEC:0001689375-22-000039:0
3,068 shares@ US$2.104.8% of flowCommon StockSEC:0001689375-22-000033:0
3,341 shares@ US$2.105.2% of flowCommon StockSEC:0001689375-22-000030:0
106 shares@ US$2.100.2% of flowCommon StockSEC:0001689375-22-000026:0
1,221 shares@ US$2.101.9% of flowCommon StockSEC:0001689375-22-000020:0
5,172 shares0Common StockSEC:0001104659-22-097874:0
10,344 shares0Common StockSEC:0001104659-22-030005:0
5,200 shares@ US$2.107.5% of flowCommon StockSEC:0001104659-21-154295:0
17 of 17 declarations
About Kreher Nerissa
KREHER NERISSA is Directrice Médicale. She has 17 filings in total, and among the sampled recent filings, purchases amount to EUR 8618 and sales to EUR 65597, over the period from 2021-12-29 to 2025-11-21. She is linked to Entrada Therapeutics, Inc. as Chief Medical Officer and to Rezolute, Inc. as Director.
